Pension Fund

Updated:

Caisse d'Assurance Vieillesse des Pharmaciens

The Caisse d'Assurance Vieillesse des Pharmaciens (CAVP) launched in 1948 as the mandatory pension pillar for France's self-employed pharmacists, from...

Caisse d'Assurance Vieillesse des Pharmaciens

The Caisse d'Assurance Vieillesse des Pharmaciens (CAVP) launched in 1948 as the mandatory pension pillar for France's self-employed pharmacists, from officine owners to biology-lab directors. It operates as one of ten professional sections under the CNAVPL umbrella, administering the basic state regime while managing autonomous complementary schemes — principally the Régime Complémentaire par Capitalisation (RCC), a collective funded plan that invests contributions rather than relying solely on pay-as-you-go levies. Philippe Berthelot holds the presidency; Thierry Desruelles serves as treasurer. Today CAVP steers a multi-asset pool across European real estate, infrastructure, and private equity, layered with fund-of-funds and direct co-investment positions. Confirmed property holdings include the 45 rue de Caumartin headquarters in Paris, the Carré de Soie office complex in Lyon, and the West Bridge building in Levallois-Perret, alongside a portfolio of mixed-use real estate funds. In private markets, the fund pursues buyout, mezzanine, and fund-of-funds strategies. CAVP participates in shareholder engagement actions with co-investors such as Mirova and Ircantec, including a published governance engagement at Danone. The institution channels capital through adjacent vehicles: InterPharmaciens provides installation loans to young pharmacists, and the Fonds d'Aides Sociales delivers hardship grants to members. CAVP became a UN-PRI signatory in September 2019 and sits on the responsible-investment commission of the Association Française des Investisseurs Institutionnels (AF2I) as well as the impact working group of the Forum pour l'Investissement Responsable (FIR). In May 2025, the fund launched its 2026 edition of the Pharmacien Libéral mémento on insurance and retirement for early-career practitioners. What sets CAVP apart from most French pension sections is its structural reliance on funded capitalisation. While sister sections operate essentially as pay-as-you-go pass-throughs, CAVP accumulates and invests member contributions through the RCC, making it behave more like a long-horizon institutional asset owner with direct real estate, infrastructure, and private-equity sleeves — a governance architecture that embeds investment returns directly into the retirement formulas of its roughly 35,000 contributing pharmacists.

General information

Firm type

Pension Fund

Year founded

1948

AUM

Undisclosed — estimated ~$10.7B (Altss estimate)

Location

Region

Europe

Country

France

City

Paris

Corporate office

45, rue de Caumartin, 75009 Paris, France

Additional offices

Villeurbanne, Lyon, France · Levallois-Perret, France

Principals

Philippe Berthelot

Président

Altss tracks 1 additional named team member for this firm — including direct investment leads, IR, and operating principals not listed on the public website.

Book a demo

Sector focus

Real EstateInfrastructurePrivate Equity

Frequently asked questions

Who runs investment decisions at CAVP?

Governance sits with the board and executive leadership under President Philippe Berthelot. CAVP reports investment decisions through its board, which is composed of elected pharmacist-representatives. The treasury function is held by Thierry Desruelles, and the fund collaborates with external co-investors such as Mirova and Ircantec on shareholder engagement actions.

How is CAVP funded, and how does its investment model differ from other French pension bodies?

Unlike most French professional pension sections that operate on a pure pay-as-you-go logic, CAVP administers the Régime Complémentaire par Capitalisation (RCC), a collective funded scheme. Pharmacists' supplementary contributions are actively invested in a diversified portfolio, and retirement benefits reflect accumulated investment returns — making CAVP a genuine institutional asset owner rather than a social-security pass-through.

What asset classes does CAVP invest in?

CAVP allocates across European real estate, infrastructure, and private equity, supplemented by fund-of-funds and mezzanine positions. The real estate portfolio includes direct holdings such as its Paris headquarters, the Carré de Soie and Organdi buildings in Lyon, and the West Bridge building in Levallois-Perret. In private equity, the fund pursues buyout and fund-of-funds strategies, and participates in shareholder engagement actions exemplified by the Danone governance engagement alongside Mirova and Ircantec.

Does CAVP maintain separate vehicles for its social and economic missions?

Yes. InterPharmaciens is a dedicated fund providing installation loans to young pharmacists and biology-lab directors. Separately, the Fonds d'Aides Sociales distributes hardship grants to members facing financial difficulty. Both vehicles are housed within the CAVP structure but serve distinct social-cohesion purposes alongside the core investment pension operation.

What is CAVP's stance on responsible investment?

CAVP has been a UN-PRI signatory since September 2019. It is an active member of the Forum pour l'Investissement Responsable (FIR), participating in the impact-investment working group, and sits on the Responsible Investment Commission of AF2I, the French association of institutional investors.

How is CAVP governed and supervised?

CAVP is one of ten professional sections of the Caisse Nationale d'Assurance Vieillesse des Professions Libérales (CNAVPL). It administers the basic state pension on CNAVPL's behalf while autonomously managing complementary schemes. Governance is provided by a board of pharmacist-representatives elected by the profession, with executive leadership under a President and Treasurer.

Who are the members of CAVP, and what is the scale of the population served?

Membership consists of all self-employed pharmacists practicing in France, including officine owners and directors of medical-biology laboratories. The fund serves both active contributors and retired beneficiaries, collectively representing the entire French liberal pharmacy profession.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo